Specificity and effector mechanisms of autoantibodies in congenital heart block
- 31 December 2006
- journal article
- review article
- Published by Elsevier in Current Opinion in Immunology
- Vol. 18 (6), 690-696
- https://doi.org/10.1016/j.coi.2006.09.012
Abstract
No abstract availableKeywords
This publication has 46 references indexed in Scilit:
- Assessment of fetal atrioventricular time intervals by tissue Doppler and pulse Doppler echocardiography: normal values and correlation with fetal electrocardiographyHeart, 2006
- Exposure and binding of selected immunodominant La/SSB epitopes on human apoptotic cellsArthritis & Rheumatism, 2005
- Autoantibodies against the serotoninergic 5-HT4 receptor and congenital heart block: A reassessmentJournal of Autoimmunity, 2005
- Identifying an early marker for congenital heart block: When is a long PR interval too long? Comment on the article by Sonesson et alArthritis & Rheumatism, 2005
- Structurally Derived Mutations Define Congenital Heart Block-Related Epitopes Within the 200-239 Amino Acid Stretch of the Ro52 ProteinScandinavian Journal of Immunology, 2005
- Fetal first‐degree heart block, or where to set the confidence limit: Comment on the article by Sonesson et alArthritis & Rheumatism, 2005
- Treatment of fetal heart block with maternal steroid therapy: case report and review of the literatureUltrasound in Obstetrics & Gynecology, 2004
- Cloning and characterization of two human Ro52-specific monoclonal autoantibodies directed towards a domain associated with congenital heart blockJournal of Autoimmunity, 2004
- Anti‐La/SSB antibodies transported across the placenta bind apoptotic cells in fetal organs targeted in neonatal lupusArthritis & Rheumatism, 2002
- Maternal Connective Tissue Disease and Congenital Heart BlockNew England Journal of Medicine, 1985